Remove Compounding Remove Magazine Remove Packaging
article thumbnail

Novo Nordisk signs $812m research deal with Deep Apple for non-GLP-1 drugs

Pharmaceutical Technology

Novo Nordisk is eyeing a cardiometabolic drug market future that is not purely dominated by incretins, after signing a $812m partnership with Deep Apple Therapeutics to access novel compounds for obesity and other diseases. Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

article thumbnail

Juvenescence enhances AI drug discovery with Ro5 acquisition

Pharmaceutical Technology

Ro5’s AI Chemistry Platform also uses advanced machine learning models and cheminformatics tools for quick compound discovery and design from hit identification to lead optimisation. Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Novo Nordisk seeks digital health partners to boost GLP-1RA weight loss outcomes

Pharmaceutical Technology

It recently initiated two more Phase III trials of its candidate CagriSema, as well as inking an $812m partnership with Deep Apple Therapeutics to access novel compounds, not GLP-1RAs, for obesity and other diseases. Can pharma tariffs “Make America Manufacture Again”? Give your business an edge with our leading industry insights.

article thumbnail

Customs simplified: the need to streamline pharma shipments

Pharmaceutical Technology

Tariffs and trade disputes are further compounding this challenge, affecting the cost structure of pharma businesses. Can pharma tariffs “Make America Manufacture Again”? The complexity of customs regulations also means lead times for shipping protract, which can have a negative impact on clinical trials and product availability.

article thumbnail

How to conduct GMP training for employee

GMPSOP

GMP/GLP and PPE training are applied to all employees, contractors and casual staff working in a GMP environment, including manufacturing, packaging, labelling, distribution, QA, QC, development, validation, engineering, IT staff and anyone whose activities could affect product quality. General Operating Procedures e. </p>

article thumbnail

Myasthenia gravis market to reach $10.3bn across 7MM by 2034

Pharmaceutical Technology

The myasthenia gravis (MG) market across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and the US) is poised to grow at a compound annual growth rate of 5.3% Can pharma tariffs “Make America Manufacture Again”? Credit: Vitalii Vodolazskyi via Shutterstock. billion in 2024 to $10.3

article thumbnail

AstraZeneca taps Chinese biotech in $5.2bn chronic disease research deal

Pharmaceutical Technology

CSPC will use its AI-powered drug discovery platform, which uses the technology to analyse the binding patterns of target proteins with existing compound molecules. Can pharma tariffs “Make America Manufacture Again”? The AI models work out targeted optimisation, advancing small molecules with the best developability.